US Hemostats Market Size study, by Type (Thrombin Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, Others) by Formulation (Matrix and Gel Hemostats, Sheet and Pad He

US Hemostats Market Size study, by Type (Thrombin Based Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, Collagen Based Hemostats, Others) by Formulation (Matrix and Gel Hemostats, Sheet and Pad Hemostats, Sponge Hemostats, Powder Hemostats, Others) by Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Others) Forecasts 2022-2032

US Hemostats Market is valued approximately USD 620 million in 2023 and is anticipated to grow with a healthy growth rate of more than 9.46% over the forecast period 2024-2032. Hemostats serve as essential surgical instruments, specifically engineered to manage bleeding by either clamping blood vessels or tissue. These tools are meticulously crafted to temporarily halt the flow of blood or bodily fluids during surgical procedures or medical interventions. Available in a variety of configurations, hemostats commonly feature hinged, scissor-like handles equipped with locking mechanisms and serrated jaws to ensure a secure grip and precise control. Additionally, the key trend of US Hemostats Market is rising incidence of chronic diseases and trauma cases that anticipated to support the market growth. The prevalence of chronic diseases such as cardiovascular disorders, cancer, and liver diseases, along with the incidence of traumatic injuries, continues to rise in the United States. This has led to a higher demand for hemostatic products in various surgical interventions, emergency care, and trauma management.

Moreover, with advancements in medical technology and an aging population, the number of surgical procedures being performed is increasing. Hemostats are essential in controlling bleeding during surgeries, leading to a higher demand for these products. Also, minimally invasive surgical techniques are becoming more popular due to their benefits such as shorter recovery times and reduced complications. Hemostats play a crucial role in these procedures by facilitating faster hemostasis without the need for extensive suturing. Additionally, other factors support the market growth are expansion of healthcare facilities, and rising incidence of chronic diseases. However, allergic responses related to hemostats are expected to impede Hemostats Market growth during 2024 to 2032.

Major market player included in this report are:
Pfizer Inc.
Baxter International Inc.
Artivion, Inc.
Company 4
Company 5
Company 6
Company 7
Company 8
Company 9
Company 10

The detailed segments and sub-segment of the market are explained below:

By Type
Thrombin Based Hemostats
Oxidized Regenerated Cellulose Based Hemostats
Combination Hemostats
Gelatin Based Hemostats
Collagen Based Hemostats
Others
By Formulation
Matrix and Gel Hemostats
Sheet and Pad Hemostats
Sponge Hemostats
Powder Hemostats
Others
By Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Others

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and Country level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.